Literature DB >> 18821043

Hippocampal head atrophy predominance in Parkinson's disease with hallucinations and with dementia.

Naroa Ibarretxe-Bilbao1, Blanca Ramírez-Ruiz, Eduardo Tolosa, María Jose Martí, Francesc Valldeoriola, Nuria Bargalló, Carme Junqué.   

Abstract

We studied regional gray matter density in the hippocampus in Parkinson's disease (PD) patients. We obtained magnetic resonance scans in 44 PD patients (PD patients with dementia (PDD) = 9, non-demented PD patients with visual hallucinations (PD + VH) = 16, and PD patients without dementia and without visual hallucinations (PD - VH) = 19) and 56 controls matched for age and years of education. A region of interest (ROI) of the hippocampus following voxel-based morphometry (VBM) procedures was used to perform group comparisons, single-case individual analysis and correlations with learning scores. Group comparisons showed that PDD patients and PD+VH patients had significant hippocampal gray matter loss compared to controls. In PDD patients, hippocampal gray matter loss involved the entire hippocampus and in PD+VH this reduction was mainly confined to the hippocampal head. 78 % of PDD patients, 31 % of PD+VH patients and 26 % of PD-VH patients had hippocampal head gray matter loss when compared to controls. These results suggest that in PD the neurodegenerative process in the hippocampus starts in the head of this structure and later spreads to the tail and that, in addition, memory impairment assessed by Rey's Auditory Verbal Learning Test (RAVLT) correlates with hippocampal head gray matter loss.

Entities:  

Mesh:

Year:  2008        PMID: 18821043     DOI: 10.1007/s00415-008-0885-8

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  31 in total

1.  Detection of grey matter loss in mild Alzheimer's disease with voxel based morphometry.

Authors:  G B Frisoni; C Testa; A Zorzan; F Sabattoli; A Beltramello; H Soininen; M P Laakso
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-12       Impact factor: 10.154

2.  In vivo neuropathology of the hippocampal formation in AD: a radial mapping MR-based study.

Authors:  G B Frisoni; F Sabattoli; A D Lee; R A Dutton; A W Toga; P M Thompson
Journal:  Neuroimage       Date:  2006-05-02       Impact factor: 6.556

3.  Cortical Lewy body disease.

Authors:  D J Burn
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-02       Impact factor: 10.154

4.  Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps.

Authors:  Liana G Apostolova; Rebecca A Dutton; Ivo D Dinov; Kiralee M Hayashi; Arthur W Toga; Jeffrey L Cummings; Paul M Thompson
Journal:  Arch Neurol       Date:  2006-05

5.  Hippocampal head size associated with verbal memory performance in nondemented elderly.

Authors:  V H Hackert; T den Heijer; M Oudkerk; P J Koudstaal; A Hofman; M M B Breteler
Journal:  Neuroimage       Date:  2002-11       Impact factor: 6.556

6.  Hippocampus and entorhinal cortex in frontotemporal dementia and Alzheimer's disease: a morphometric MRI study.

Authors:  M P Laakso; G B Frisoni; M Könönen; M Mikkonen; A Beltramello; C Geroldi; A Bianchetti; M Trabucchi; H Soininen; H J Aronen
Journal:  Biol Psychiatry       Date:  2000-06-15       Impact factor: 13.382

7.  Temporal lobe atrophy on MRI in Parkinson disease with dementia: a comparison with Alzheimer disease and dementia with Lewy bodies.

Authors:  C W C Tam; E J Burton; I G McKeith; D J Burn; J T O'Brien
Journal:  Neurology       Date:  2005-03-08       Impact factor: 9.910

8.  Changes in hippocampal volume and shape across time distinguish dementia of the Alzheimer type from healthy aging.

Authors:  Lei Wang; Jeffrey S Swank; Irena E Glick; Mokhtar H Gado; Michael I Miller; John C Morris; John G Csernansky
Journal:  Neuroimage       Date:  2003-10       Impact factor: 6.556

9.  Age and dementia-associated atrophy predominates in the hippocampal head and amygdala in Parkinson's disease.

Authors:  Thomas P Bouchard; Nikolai Malykhin; W R Wayne Martin; Christopher C Hanstock; Derek J Emery; Nancy J Fisher; Richard M Camicioli
Journal:  Neurobiol Aging       Date:  2007-03-26       Impact factor: 4.673

10.  Hippocampal volumes in Alzheimer's disease, Parkinson's disease with and without dementia, and in vascular dementia: An MRI study.

Authors:  M P Laakso; K Partanen; P Riekkinen; M Lehtovirta; E L Helkala; M Hallikainen; T Hanninen; P Vainio; H Soininen
Journal:  Neurology       Date:  1996-03       Impact factor: 9.910

View more
  41 in total

Review 1.  An update expert opinion on management and research strategies in Parkinson's disease psychosis.

Authors:  Jennifer G Goldman; Christina L Vaughan; Christopher G Goetz
Journal:  Expert Opin Pharmacother       Date:  2011-06-02       Impact factor: 3.889

2.  Altered hippocampal synaptic physiology in aged parkin-deficient mice.

Authors:  Jesse E Hanson; Adrienne L Orr; Daniel V Madison
Journal:  Neuromolecular Med       Date:  2010-03-16       Impact factor: 3.843

Review 3.  Neuroimaging and cognition in Parkinson's disease dementia.

Authors:  Lisa C Silbert; Jeffrey Kaye
Journal:  Brain Pathol       Date:  2010-05       Impact factor: 6.508

4.  Visuospatial functioning is associated with sleep disturbance and hallucinations in nondemented patients with Parkinson's disease.

Authors:  Krista Specketer; Cyrus P Zabetian; Karen L Edwards; Lu Tian; Joseph F Quinn; Amie L Peterson-Hiller; Kathryn A Chung; Shu-Ching Hu; Thomas J Montine; Brenna A Cholerton
Journal:  J Clin Exp Neuropsychol       Date:  2019-06-10       Impact factor: 2.475

Review 5.  Gray matter atrophy in Parkinson's disease with dementia: evidence from meta-analysis of voxel-based morphometry studies.

Authors:  Ping Lei Pan; Hai Cun Shi; Jian Guo Zhong; Pei Rong Xiao; Yuan Shen; Li Juan Wu; Yuan Ying Song; Gui Xiang He; Hua Liang Li
Journal:  Neurol Sci       Date:  2012-11-27       Impact factor: 3.307

6.  Verbal memory is associated with structural hippocampal changes in newly diagnosed Parkinson's disease.

Authors:  Mona K Beyer; Kolbjorn S Bronnick; Kristy S Hwang; Niels Bergsland; Ole Bjorn Tysnes; Jan Petter Larsen; Paul M Thompson; Johanne H Somme; Liana G Apostolova
Journal:  J Neurol Neurosurg Psychiatry       Date:  2012-11-15       Impact factor: 10.154

7.  Grey matter hypometabolism and atrophy in Parkinson's disease with cognitive impairment: a two-step process.

Authors:  Rafael González-Redondo; David García-García; Pedro Clavero; Carmen Gasca-Salas; Reyes García-Eulate; José L Zubieta; Javier Arbizu; José A Obeso; María C Rodríguez-Oroz
Journal:  Brain       Date:  2014-06-20       Impact factor: 13.501

8.  Visual hallucinations are associated with hyperconnectivity between the amygdala and visual cortex in people with a diagnosis of schizophrenia.

Authors:  Judith M Ford; Vanessa A Palzes; Brian J Roach; Steven G Potkin; Theo G M van Erp; Jessica A Turner; Bryon A Mueller; Vincent D Calhoun; Jim Voyvodic; Aysenil Belger; Juan Bustillo; Jatin G Vaidya; Adrian Preda; Sarah C McEwen; Daniel H Mathalon
Journal:  Schizophr Bull       Date:  2014-03-11       Impact factor: 9.306

Review 9.  Minor hallucinations in Parkinson disease: A subtle symptom with major clinical implications.

Authors:  Abhishek Lenka; Javier Pagonabarraga; Pramod Kumar Pal; Helena Bejr-Kasem; Jaime Kulisvesky
Journal:  Neurology       Date:  2019-07-09       Impact factor: 9.910

10.  Oral Administration of Silibinin Ameliorates Cognitive Deficits of Parkinson's Disease Mouse Model by Restoring Mitochondrial Disorders in Hippocampus.

Authors:  Xiumin Liu; Chenkang Wang; Weiwei Liu; Siaoyu Song; Jianing Fu; Toshihiko Hayashi; Kazunori Mizuno; Shunji Hattori; Hitomi Fujisaki; Takashi Ikejima
Journal:  Neurochem Res       Date:  2021-06-07       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.